The possible direct effects of CXCL16/CXCR6 on prostate cancer cells notwithstanding, because CXCR6 is best described as a T cell chemokine receptor, we investigated activities for CXCL16/CXCR6 on prostate-cancer associated T cells that might contribute indirectly to the formation and growth of the cancer. Here, CXCL16 is linked to prostate carcinoma.